Title
Ambiguous Discourse: Feminist Narratology And British Women Writers,New
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Carefully melding theory with close readings of texts, the contributors to Ambiguous Discourse explore the role of gender in the struggle for narrative control of specific works by British writers Jane Austen, Virginia Woolf, Anita Brookner, Angela Carter, Jeanette Winterson, and Mina Loy. This collection of twelve essays is the first book devoted to feminist narratologythe combination of feminist theory with the study of the structures that underpin all narratives. Until recently, narratology has resisted the advances of feminism in part, as some contributors argue, because theory has replicated past assumptions of male authority and point of view in narrative. Feminist narratology, however, contextualizes the cultural constructions of gender within its study of narrative strategies. Nine of these essays are original, and three have been revised for publication in this volume. The contributors are Melba CuddyKeane, Denise Delorey, Rachel Blau DuPlessis, Susan Stanford Friedman, Janet Giltrow, Linda Hutcheon, Susan S. Lanser, Alison Lee, Patricia Matson, Kathy Mezei, Christine Roulston, and Robyn Warhol.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.